Sorrento Therapeutics Inc
Change company Symbol lookup
Select an option...
SRNE Sorrento Therapeutics Inc
EOG EOG Resources Inc
CPLP Capital Product Partners LP
BVNNF Bevcanna Enterprises Inc
OCUL Ocular Therapeutix Inc
GOOG Alphabet Inc
BAC Bank of America Corp
ED Consolidated Edison Inc
FRAN Francesca's Holdings Corp
CWBHF Charlotte's Web Holdings Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Sorrento Therapeutics, Inc. is a clinical-stage and commercial biopharma company. The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next generation of cancer therapeutics. These modalities include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy (DAR-T), antibody-drug conjugates (ADC), as well as bispecific antibody approaches. Additionally, Sorrento Therapeutics segment also includes Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system to potentially achieve improved efficacy and fewer adverse effects than standard parenteral immunotherapy. The Scilex segment is organized around its non-opioid pain management operations.

Closing Price
$9.43
Day's Change
-0.05 (-0.53%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.46
Day's Low
8.64
Volume
(Average)
Volume:
35,168,066

10-day average volume:
34,365,421
35,168,066

Thinking about trading options or stock in Sorrento Therapeutics, Chegg Inc, Peloton Interactive, Eli Lilly, or Tesla?

9:43 am ET August 3, 2020 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for SRNE, CHGG, PTON, LLY, and TSLA.

https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- SRNE: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=SRNE&prnumber=080320201

-- CHGG: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=CHGG&prnumber=080320201

-- PTON: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PTON&prnumber=080320201

-- LLY: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=LLY&prnumber=080320201

-- TSLA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=TSLA&prnumber=080320201

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

https://c212.net/c/img/favicon.png?sn=CG80815&sd=2020-08-03

View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-sorrento-therapeutics-chegg-inc-peloton-interactive-eli-lilly-or-tesla-301104694.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG80815&Transmission_Id=202008030931PR_NEWS_USPR_____CG80815&DateId=20200803

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.